Biktarvy, formally known as bictegravir sulfate, is a potent single-tablet therapy for managing HIV infection. This medication combines three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the HIV's ability to multiply within the body, remarkably decreasing the viral burden. For many in